The company said its revenue for Q3 2025 was $1,105 million, up 13% as reported and 12% organically. Companion Animal Group rose 14% as reported, and Livestock, Poultry and Dairy rose 17% as reported.

1. 01

   The company said its revenue for Q3 2025 was $1,105 million, up 13% as reported and 12% organically. Companion Animal Group rose 14% as reported, and Livestock, Poultry and Dairy rose 17% as reported.

2. 02

   IDEXX said diluted earnings per share for Q3 were $3.40, up 21% as reported and 15% on a comparable basis. Operating margin was 32.1%, up 100 basis points as reported and 120 basis points on a comparable basis.

3. 03

   The company said CAG Diagnostics capital instrument revenue for Q3 rose 74% as reported and 71% organic. This included the benefit of more than 1,700 IDEXX inVue Dx placements.

4. 04

   The company gave its full-year 2025 revenue outlook as $4,270 million to $4,300 million, and said it raised the midpoint by $43 million from the prior outlook of $4,205 million to $4,280 million. The EPS outlook is $12.81 to $13.01, versus the prior outlook of $12.40 to $12.76.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.